Edallia Pharmaceuticals Private Limited
Pharmaceutical trading company incorporated in 2018, based in Maharashtra.
2018 | Pune, Maharashtra (India) | Active
Edallia Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 19.95%
- Profit Growth 262.81%
- Ebitda 100.63%
- Net Worth 57.72%
- Total Assets -1.59%
About Edallia Pharmaceuticals
Edallia Pharmaceuticals Private Limited (EPPL) is a Private Limited Indian Non-Government Company incorporated in India on 12 April 2018 (Six years and 11 months 16 days old ). Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Shubhangi Parmale and Amol Parmale serve as directors at the Company.
Company Details
- Location
Pune, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U74999PN2018PTC175988
- Company No.
175988
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Apr 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Pharma
What products or services does Edallia Pharmaceuticals Private Limited offer?
Edallia Pharmaceuticals Private Limited offers a wide range of products and services, including Cardiovascular Drugs & Medication, Kidney Drugs, Common Disease Medicines, Pharmaceutical Capsules, Pharmaceutical Medicine, Digestive System Drugs & Medicines, Antacid Drugs, Pre & Probiotic Capsule.
Who are the key members and board of directors at Edallia Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shubhangi Parmale  | Director | 12-Apr-2018 | Current |
| Amol Parmale | Director | 31-Dec-2019 | Current |
Financial Performance of Edallia Pharmaceuticals.
Edallia Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 19.95% increase. The company also saw a substantial improvement in profitability, with a 262.81% increase in profit. The company's net worth Soared by an impressive increase of 57.72%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Edallia Pharmaceuticals?
Unlock access to Edallia Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Edallia Pharmaceuticals?
Unlock and access historical data on people associated with Edallia Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Edallia Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Edallia Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Edallia Pharmaceuticals
Recent activity within the organization
- Annual General Meeting
Edallia Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
- Balance Sheet
Edallia Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Pune.
- Director Appointment
Amol Ashok Parmale was appointed as a Director was appointed as a Director on 31 Dec 2019 & has been associated with this company since 5 years 2 months .
- Director Appointment
Shubhangi Parmale was appointed as a Director was appointed as a Director on 12 Apr 2018 & has been associated with this company since 6 years 11 months .
- Company Incorporation
Edallia Pharmaceuticals Private Limited was registered on 12 Apr 2018 with Roc Pune & aged 6 years 11 months as per MCA records.
Frequently asked questions
What is the Incorporation or founding date of Edallia Pharmaceuticals Private Limited?
Edallia Pharmaceuticals Private Limited was incorporated on 12 Apr 2018.
What is authorized share capital and paid-up capital of Edallia Pharmaceuticals Private Limited?
The authorized share capital of Edallia Pharmaceuticals Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.
Who are the current board members & directors of Edallia Pharmaceuticals Private Limited?
Currently 2 directors are associated with Edallia Pharmaceuticals Private Limited.
- Shubhangi Parmale
- Amol Ashok Parmale
What is the registered address of Edallia Pharmaceuticals Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Edallia Pharmaceuticals Private Limited is S No 22 Prime Heritage F 5 Mahavir Nagar Near Datta Mandir Sukhsagar India, Katraj Pune, Maharashtra, 411046.
What is the corporate identification number (CIN) and company number of Edallia Pharmaceuticals Private Limited?
The corporate identification number (CIN) of Edallia Pharmaceuticals Private Limited is U74999PN2018PTC175988 and the company number is 175988 as per Ministry of Corporate Affairs (MCA).
What has been the recent revenue trend for Edallia Pharmaceuticals Private Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Edallia Pharmaceuticals Private Limited has risen by 19.95%.
What change has been observed in the net worth of Edallia Pharmaceuticals Private Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Edallia Pharmaceuticals Private Limited has experienced an upsurge of 57.72%.
When was the last Balance Sheet of Edallia Pharmaceuticals Private Limited filed with the ROC?
The most recent Balance Sheet for Edallia Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2023.
People also Viewed
PI
Pradnya InamdarDirectorRJ
Rohit JoshiDirector